Skip to search formSkip to main contentSkip to account menu

ABT 127

Known as: ABT-127, ABT127 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Double Dissociation of the Effects of Haloperidol and the Dopamine D3 Receptor Antagonist ABT-127 on Acquisition vs. Expression of Cocaine-Conditioned Activity in Rats
Dopamine receptors play a critical role in reward-related learning, but receptor subtypes may be differentially involved. D2… 
2007
2007
DOUBLE DISSOCIATION OF THE EFFECTS OF HALOPERIDOL AND THE DOPAMINE D 3 RECEPTOR-SPECIFIC ANTAGONIST ABT-127 ON ACQUISITION VS . EXPRESSION OF COCAINE CONDITIONED ACTIVITY
2006
2006
ABT‐127, a novel Dopamine D3 Receptor Antagonist: Cardiovascular Profile in the Anesthetized Dog
ABT‐127 is a novel and orally efficacious dopamine D3‐selective antagonist targeted for the treatment of schizophrenia (pre… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)